Prescription and over-the-counter medication recalls
Drug recalls come from the FDA's drug enforcement reports. They range from a wrong label to a product that could be harmful, and the risk level on each notice is the FDA's own classification. Never stop a prescribed medication on the strength of a recall notice alone — the notice will say whether to return it, and your prescriber or pharmacist decides what replaces it.
4,474 stored notices, reported between Jun 20, 2012 and Sep 9, 2026. Newest first.
Reported Oct 10, 2018
Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, Rx only, Distributed by Pfizer Labs,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Pfizer Inc.
FDA (openFDA drug enforcement)
Reported Oct 10, 2018
Thyroid Powder 25kg/drum, US Pharmacopoeia, Sichuan Friendly Pharmaceutical Co., LTD, Production Address: No. 680,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Sichuan Friendly Pharmaceutical Co.,Ltd.
FDA (openFDA drug enforcement)
Reported Oct 10, 2018
Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Teva Pharmaceuticals USA
FDA (openFDA drug enforcement)
Reported Oct 3, 2018
Levofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDC 36000-047-24),…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Baxter Healthcare Corporation
FDA (openFDA drug enforcement)
Reported Oct 3, 2018
Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. Rx only. 180-count bottle. Distributed by:…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Boehringer Ingelheim Pharmaceuticals, Inc.
FDA (openFDA drug enforcement)
Reported Oct 3, 2018
Zoledronic Acid Injection, 5mg/100 mL (0.05 mg/mL) 100ml vial, Rx Only. Mfd By: Gland Pharma Limited D.P. Pally - 500…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Dr. Reddy's Laboratories, Inc.
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Oct 3, 2018
Montelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero Labs Limited, Unit V, Polepally,…
High riskUsing this product could cause serious injury, illness or death — stop using it now.Hetero Labs Limited Unit V
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Oct 3, 2018
Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway,…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Hetero Labs, Ltd. - Unit III
FDA (openFDA drug enforcement)
Reported Oct 3, 2018
Minivelle (estradiol transdermal system) Patches Delivers 0.1 mg/day, a) 2 count and b) 8 count boxes, Rx only, , Mfd.…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Noven Pharmaceuticals, Inc.
3 more products in this recall
FDA (openFDA drug enforcement)
Reported Sep 26, 2018
0.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation Deerfield, IL 60015 -- NDC…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Baxter Healthcare Corporation
FDA (openFDA drug enforcement)
Reported Sep 26, 2018
Skin Irritation & Itch Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, Distributed…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Beaumont Bio-med, Inc.
7 more products in this recall
FDA (openFDA drug enforcement)
Reported Sep 26, 2018
Tizanidine HCl Tablets, USP 2mg, 150-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited Srilakulam - 532…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Dr. Reddy's Laboratories, Inc.
FDA (openFDA drug enforcement)
Reported Sep 26, 2018
Bupropion Hydrochloride ER Tablets, USP 150 mg, packaged in a) 90-count bottle (NDC 69097-875-05), Manufactured for:…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.InvaGen Pharmaceuticals, Inc.
FDA (openFDA drug enforcement)
Reported Sep 26, 2018
MethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista Pharmaceuticals Inc. Salisbury,…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Jubilant Cadista Pharmaceuticals, Inc.
FDA (openFDA drug enforcement)
Reported Sep 26, 2018
Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle, Rx only, Manufactured by: Novel Laboratories, Inc.…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Lupin Somerset
FDA (openFDA drug enforcement)
Reported Sep 26, 2018
Norepinephrine 4 mg (16 mcg/mL) added to 5% Dextrose 250 mL Bag Preservative Free, Rx only, QuVa Pharma, 519 Route 173,…
High riskUsing this product could cause serious injury, illness or death — stop using it now.QuVa Pharma, Inc.
FDA (openFDA drug enforcement)
Reported Sep 26, 2018
Lamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For: TORRENT…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Torrent Pharma Inc.
FDA (openFDA drug enforcement)
Reported Sep 19, 2018
Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham,…
High riskUsing this product could cause serious injury, illness or death — stop using it now.Accord Healthcare, Inc.
FDA (openFDA drug enforcement)
Reported Sep 19, 2018
Compulsin, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: HelloLife, Inc. 4635 40th St SE, Grand…
High riskUsing this product could cause serious injury, illness or death — stop using it now.Hellolife
3 more products in this recall
FDA (openFDA drug enforcement)
Reported Sep 19, 2018
Diltiazem HCl Extended-Release Capsules, USP 120 mg 100-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown,…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Mylan Pharmaceuticals Inc.
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Sep 19, 2018
Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by:…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Par Pharmaceutical, Inc.
FDA (openFDA drug enforcement)
Reported Sep 19, 2018
Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Vial, Rx only, Sterile, Manufactured for: Hospira,…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Pfizer Inc.
FDA (openFDA drug enforcement)
Reported Sep 19, 2018
Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL Injection, 100 mL Single Dose Container bag, Rx Only, SCA…
High riskUsing this product could cause serious injury, illness or death — stop using it now.SCA Pharmaceuticals, Inc.
FDA (openFDA drug enforcement)
Reported Sep 19, 2018
Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.United Therapeutics Corp.
FDA (openFDA drug enforcement)
Free recall alerts
Get alerted about new Medication recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.
Related categories
RecallNow is not a government agency. Every notice above was published by the FDA, USDA FSIS or CPSC and links back to its source. Browse the whole archive.